Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Ardeshir states, "This new hypothesis could help protect newborns in high-risk areas during the most vulnerable period of ...

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at least three years.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.